Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy (Q46378129)

21 December 2017

title

Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy (English)

1 reference

21 December 2017

1 reference

21 December 2017

author name string

Philippe Couvert

1 reference

21 December 2017

Philippe Giral

1 reference

21 December 2017

Sylvie Dejager

1 reference

21 December 2017

Jessie Gu

1 reference

21 December 2017

M John Chapman

1 reference

21 December 2017

Eric Bruckert

1 reference

21 December 2017

Alain Carrié

1 reference

21 December 2017

publication date

1 September 2008

1 reference

21 December 2017

published in

Pharmacogenomics

1 reference

21 December 2017

volume

1 reference

21 December 2017

issue

1 reference

21 December 2017

page(s)

1217-1227

1 reference

21 December 2017

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Statin safety: lessons from new drug applications for marketed statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Transporter-mediated drug delivery: recent progress and experimental approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

The superfamily of organic anion transporting polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Role of OATP transporters in the disposition of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Pharmacogenomics of organic anion-transporting polypeptides (OATP).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

LDA—a java-based linkage disequilibrium analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

An association study of 43 SNPs in 16 candidate genes with atorvastatin response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Global analysis of genetic variation in SLCO1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.9.1217

10.2217/14622416.9.9.1217

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017